A newly formed biotech launched out of George Daley’s Harvard lab adds global players to its syndicate, bringing its haul to $83M
The prospect of finding new drugs that can modulate RNA proteins to help fight diseases has brought in a pair of new backers for 28 …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
